🔴 Intuitive Surgical is trading 9.3% down today after maintaining procedure guidance and warning of macro headwinds

Intuitive Surgical is trading 9.3% down at $364.94 in pre-market following a post-earnings reassessment that prioritized a cautious outlook over a Q2 earnings beat.

• The company exceeded Q2 expectations with $2.89B in revenue and $2.80 non-GAAP EPS, supported by 16% procedure growth and strong Da Vinci 5 adoption.
• Investors reacted to management maintaining 2026 procedure growth guidance at 13.5%–15.5% while flagging a U.S. slowdown and broader macro headwinds.
• The sharp decline reflects concerns regarding the stock's premium valuation and a conservative forward-looking stance despite robust operational performance.